ASLAN001
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ASLAN001, covering 2015-01-14 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer [Phase 2]